YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Big Pharma Rumor Mill


January 16, 2013 | It seems to be a season of shake ups in Big Pharma, and Derek Lowe is trading theories. Right now, the predominant ones include a split at Pfizer, possibly leaving the small-molecule work without a home; and some possible changes at AstraZeneca as the new CEO cleans house. In the Pipeline
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact  Jay Mulhern, (781) 972-1359, jmulhern@healthtech.com.